<DOC>
	<DOC>NCT00000337</DOC>
	<brief_summary>The purpose of this study is to determine the effects of selegiline on the subjective and physiological effects of cocaine challenge in chronic crack abusers, and to evaluate clinical safety issues pertaining to selegeline, to cocaine and their interaction in a chronic crack dependent population.</brief_summary>
	<brief_title>Infusion Laboratory: Protocol 1 - Selegeline - 2</brief_title>
	<detailed_description>To develop a medication for the treatment of cocaine addiction using a medical human physio-neuro-psycho-immunology laboratory setting. To characterize this cocaine abusing population on a variety of psychological and physicologically measures over time from withdrawal through pere and post cocaine administration. To determine the effects of selegeline on the subjective and physiological effects of cocaine challenge in chronic crack abusers. To evaluate clinical safety issues pertaining to selegeline, to cocaine and their interaction in a chronic crack dependent population.</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<criteria>M/F, ages 2150. Meet DSMIV criteria for cocaine dependence. Agree to conditions of the study and sign informed consent. Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics. Acute hepatitis. Other medical condtions that deem participation to be unsafe.</criteria>
	<gender>All</gender>
	<minimum_age>31 Years</minimum_age>
	<maximum_age>47 Years</maximum_age>
	<verification_date>August 1996</verification_date>
	<keyword>cocaine dependence</keyword>
</DOC>